0.7405
전일 마감가:
$0.7504
열려 있는:
$0.75
하루 거래량:
52,215
Relative Volume:
0.14
시가총액:
$57.51M
수익:
$234.00K
순이익/손실:
$-23.11M
주가수익비율:
-0.7195
EPS:
-1.0292
순현금흐름:
$-20.71M
1주 성능:
-7.48%
1개월 성능:
+8.77%
6개월 성능:
+4.22%
1년 성능:
-37.27%
Envoy Medical Inc Stock (COCH) Company Profile
명칭
Envoy Medical Inc
전화
651-361-8000
주소
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
COCH
Envoy Medical Inc
|
0.7451 | 57.12M | 234.00K | -23.11M | -20.71M | -1.0292 |
|
ABT
Abbott Laboratories
|
116.30 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.31 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.86 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
50.44 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.48 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-31 | 개시 | H.C. Wainwright | Buy |
| 2024-06-24 | 개시 | Ascendiant Capital Markets | Buy |
Envoy Medical Inc 주식(COCH)의 최신 뉴스
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
HC Wainwright Cuts Envoy Medical (NASDAQ:COCH) Price Target to $2.00 - MarketBeat
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com Canada
Envoy (COCH) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Price Move - Vinanet
Envoy (COCH) Q1 2026 Earnings: The Bottom-Line Figure Beats Its Comparison for the Current Session - Vinanet
Envoy (COCHW) Momentum: Trades in a Narrow Directional Range at $0.05 at the Close - Vinanet
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsBullish Percent Index - Vinanet
Price to sales forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street Its The Platformsinvestor distribution. - ACCESS Newswire
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA - Caledonian Record
The Beat: Target names AI chief, Niron gets White House backing, Envoy chases cochlear market - The Business Journals
Envoy Medical Inc. (NASDAQ: COCHW) Stock Price, News & Analysis - Kalkine
Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for Investors - TipRanks
Envoy Medical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Envoy Medical earnings beat, revenue fell short of estimates - Investing.com
Envoy Medical (NASDAQ: COCH) raises cash, advances fully implanted cochlear implant - Stock Titan
Envoy Medical Releases Q2 2026 Financial Results - AlphaStreet
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Envoy Medical Q2 Results: EPS beats estimate, sales miss - scanx.trade
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q Summary - TradingView
Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - Stock Titan
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical (COCH) Reports Q2 2026 Results, Submits First FDA PMA Module and Posts Strong Acclaim® Cochlear Implant Clinical Data - kalkine.ca
Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Envoy Medical (COCH) Holds Near $0.68 as Hearing Implant Developer Digests Post-Listing VolatilityAdvance Decline Line - dars.gov.et
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 3.61% Share GainEarnings Trend Analysis - Vinanet
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCHW - TradingView
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCH - TradingView
Envoy Medical Inc (COCH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Capital Markets initiates Envoy Medical stock with buy rating By Investing.com - Investing.com Canada
Envoy Medical Inc (COCH) Cash Flow - TradingKey
Envoy Medical Inc (COCH) Income Statement - TradingKey
Envoy Medical Inc (COCH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Envoy Medical Warrants Edge Higher Amidst Tight Trading RangeStandard Deviation - dars.gov.et
Envoy Medical Inc (COCH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
COCH Q1 2026 Earnings: Strong EPS Beat Offsets Lack of Reported RevenueGuidance vs Actual - Vinanet
Envoy Medical Inc Warrant (COCHW) Surges 20% Amid Low-Price Volatility – Key Levels to WatchSwing Entry Signals - Vinanet
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo Finance
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant - Sahm
Exclusive: Envoy Medical builds momentum with improved cochlear implant trial results - MSN
Envoy Medical hits 3-month milestone in trial f... - Pluang
All 56 patients reach 3 months in Envoy Medical's hearing implant trial - Stock Titan
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. I - GuruFocus
Enterprise value to revenue forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN) - New Castle News
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Envoy Medical (COCH) Sheds 7.7% as Stock Tests Key Support at $0.66ETF NAV Deviation - dars.gov.et
Envoy Medical Inc Warrant (COCHW) Surges 36.7%: A Volatile Move Near Key LevelsATR Trailing Stop - dars.gov.et
Envoy Medical Inc (COCH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Envoy Medical Inc 주식 (COCH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
자본화:
|
볼륨(24시간):